Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimer Darsalia

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
BMC Medicine|March 25, 2026
The need for clinical studies assessing whether weight loss improves functional outcome after stroke in diabetesEllen Vercalsteren, Michael V Mazya, Thomas Nyström, et al.
Frontiers in Neurology|May 30, 2019
Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and StrokeVladimer Darsalia, Odd Erik Johansen, Grazyna Lietzau, et al.
Reviews in Endocrine & Metabolic Disorders|April 30, 2014
GLP-1R activation for the treatment of stroke: updating and future perspectivesVladimer Darsalia, David Nathanson, Thomas Nyström, et al.
Neuropeptides|September 18, 2012
The specific VPAC2 agonist Bay 55-9837 increases neuronal damage and hemorrhagic transformation after stroke in type 2 diabetic ratsVladimer Darsalia, Shiva Mansouri, Petra Wolbert, et al.
Cellular and Molecular Neurobiology|May 25, 2020
The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke RecoveryFausto Chiazza, Hiranya Pintana, Grazyna Lietzau, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 12, 2015
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of strokeVladimer Darsalia, Martin Larsson, David Nathanson, et al.
Journal of Neuroscience Research|December 21, 2011
Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitateShiva Mansouri, Henrik Ortsäter, Otto Pintor Gallego, et al.
Bioscience Reports|June 12, 2024
Nuclear magnetic resonance spectroscopy reveals biomarkers of stroke recovery in a mouse model of obesity-associated type 2 diabetesJoão P P Vieira, Dimitra Karampatsi, Ellen Vercalsteren, et al.
Clinical Science (London, England : 1979)|June 26, 2019
Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneuronsHiranya Pintana, Grazyna Lietzau, Ingrid Lovise Augestad, et al.
The European Journal of Neuroscience|June 26, 2003
Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following strokeElin Gustafsson, Gunnar Andsberg, Vladimer Darsalia, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
BMC Medicine|March 25, 2026
The need for clinical studies assessing whether weight loss improves functional outcome after stroke in diabetesEllen Vercalsteren, Michael V Mazya, Thomas Nyström, et al.
Frontiers in Neurology|May 30, 2019
Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and StrokeVladimer Darsalia, Odd Erik Johansen, Grazyna Lietzau, et al.
Reviews in Endocrine & Metabolic Disorders|April 30, 2014
GLP-1R activation for the treatment of stroke: updating and future perspectivesVladimer Darsalia, David Nathanson, Thomas Nyström, et al.
Neuropeptides|September 18, 2012
The specific VPAC2 agonist Bay 55-9837 increases neuronal damage and hemorrhagic transformation after stroke in type 2 diabetic ratsVladimer Darsalia, Shiva Mansouri, Petra Wolbert, et al.
Cellular and Molecular Neurobiology|May 25, 2020
The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke RecoveryFausto Chiazza, Hiranya Pintana, Grazyna Lietzau, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 12, 2015
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of strokeVladimer Darsalia, Martin Larsson, David Nathanson, et al.
Journal of Neuroscience Research|December 21, 2011
Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitateShiva Mansouri, Henrik Ortsäter, Otto Pintor Gallego, et al.
Bioscience Reports|June 12, 2024
Nuclear magnetic resonance spectroscopy reveals biomarkers of stroke recovery in a mouse model of obesity-associated type 2 diabetesJoão P P Vieira, Dimitra Karampatsi, Ellen Vercalsteren, et al.
Clinical Science (London, England : 1979)|June 26, 2019
Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneuronsHiranya Pintana, Grazyna Lietzau, Ingrid Lovise Augestad, et al.
The European Journal of Neuroscience|June 26, 2003
Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following strokeElin Gustafsson, Gunnar Andsberg, Vladimer Darsalia, et al.
Pageof 6